NFKB1 and breast cancer: Many studies have reported that chlorogenic acid has immense antitumor activity against breast cancer by inhibiting NF-κB, inhibiting the β-catenin of the Wnt signaling pathway, and also inhibiting proliferation, viability, and suppressing invasion and migration of breast cancer cells (Zeng et al., 2021; Bender and Atalay, 2021).